Sanofi is a leading French pharmaceutical company headquartered in Gentilly, France.
Image: company website
The company was founded in 1994 by Jean-Francois Dehecq, and was initially formed by the merger between Sanofi and Aventis in 2004. Later in 2011, the company renamed itself as “Sanofi”, and is currently the 5th largest pharmaceutical group in the world in terms of its sales as per the IMS data.
The 3 major business areas the company operates in are Pharmaceuticals, Human Vaccine systems and Animal Health. Human Vaccine systems include vaccines providing protection from 20 infectious diseases covering both bacterial and viral diseases. Animal Health segment comprises of anti-parasitic, anti-infective, anti-inflammatories, and anti-ulcerate vaccines. The company’s increased focus in research and development has allowed it to gradually move from manufacturing traditional drugs to towards manufacturing biotechnological medicines.
The company is known for its commitment in improving access to healthcare and servicing people in dealing with health issues and enable them to lead a healthier life. Operating from disease prevention to treatment, Sanofi has always transformed scientific research into healthcare solutions, in areas like human vaccines, Generics, Sanofi Genzyme, Diabetes, Oncology, multiple sclerosis, immunology, rare diseases, and consumer healthcare.
The company currently employs more than 1.1 lakh people and have nearly 110 industrial sites and 20 Research and Development sites. It has its operations in over 80 nations covering more than 300 million people. Its markets can be segmented into 4 categories with United states covering 36.2%, Western Europe covering 21.7%, Emerging markets covering 32.4%, Rest of the world covering 9.7% of the company’s sales.